This brand name is authorized in New Zealand.
The drug ENERLYTE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
LX22YL083G - DEXTROSE MONOHYDRATE
|
|
Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body. |
|
2
|
UNII
660YQ98I10 - POTASSIUM CHLORIDE
|
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
|
3
|
UNII
6FO62KCQ7A - DISODIUM HYDROGEN CITRATE
|
|
Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. |
|
4
|
UNII
451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NZ | Medicines and Medical Devices Safety Authority | 11513 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.